About 193,000 results
Any time
Open links in new tab
- UnprovenIn a decision that shocked some observers, key advisers to the US Food and Drug Administration (FDA) voted that the effectiveness of the party drug MDMA for treating post-traumatic stress disorder is unproven. Members of an independent scientific advisory committee voted 9 to 2 that human trials of MDMA did not prove its efficacy.www.nature.com/articles/d41586-024-01622-3
- People also ask
FDA rejects MDMA, disappointing drugmaker Lykos and …
See results only from npr.orgFDA advisers reject MDMA a…
A panel of experts advising the Food and Drug Administration on the use of the …
FDA advisers reject MDMA as treatment for PTSD : Shots - NPR
- Events of FDA rejects MDMA for PTSD
FDA declines to approve novel MDMA therapy to treat PTSD, with …
Why FDA Panel Rejected MDMA Therapy—And What’s Next For
MDMA therapy for PTSD rejected by FDA panel - Nature
WEBJun 5, 2024 · Scientific advisers to the US Food and Drug Administration rejected the effectiveness and safety of MDMA treatment for post-traumatic stress disorder. They raised concerns about the study design, the role of …
FDA Panel Rejects Use of MDMA for Treatment of PTSD - The New …
FDA advisers vote against first MDMA therapy to treat PTSD
FDA rejects MDMA-assisted therapy for PTSD - NBC News
FDA rejects MDMA for treating PTSD, calls for redo of study, …
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug ...